MEET THE FACULTY

Matti Aapro
Show full Bio
Janet Abrahm
Dr. Janet Abrahm is a Professor of Medicine at Harvard Medical School in the Division of Adult Palliative Care in the Department of Psychosocial Oncology and Palliative Care at the Dana Farber Cancer Institute and the Brigham and Women’s Hospital. She collaborates with Dr. Mary Cooley in NIH-funded research into unique Clinical Decision Support systems for symptom management in cancer patients. The third edition of her book, "A Physician’s Guide to Pain and Symptom Management in Cancer Patients", will be published in September 2014 by Johns Hopkins University Press. Show full Bio
Sam Ahmedzai
Show full Bio
Marie-Laure Allouis
Ma présentation pour le congrès porte sur l'altération de l'image corporelle du patient engendrée par la maladie et les traitements Show full Bio
Rui Amaral Mendes
Prof. Rui Amaral Mendes is Professor of Oral Medicine, Oral Oncology and Oral Surgery at the Catholic University of Portugal and Clinical Director of the University’s Clinic. Head of the Bone Complications Section of the Oral Care Study Group, Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO), he is member of the Editorial Board of “Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology” and “Journal of Carcinogenesis & Mutagenesis” and Associate Editor of the “British Medical Journal – Case Reports”. Show full Bio
Andrea Antonuzzo
Medical Oncologist with experience in the field of supportive and palliative care Chief of Supportive Care Team - Medical Oncology - Pisa (Polo Oncologico - Azienda Ospedaliero-Universitaria) Co-founder of NICSO (Italian Network for Supportive Care in Oncology) Show full Bio
Fred Ashbury
Dr. Fred Ashbury is Editor-in-Chief, Supportive Care in Cancer, and Professor, Illawarra Medical and Health Research Institute at the University of Wollongong, New South Wales, Australia. Show full Bio
Siri Beier-Jensen
Show full Bio
David Blum
Show full Bio
Christine Boers-Doets
Christine is currently a PhD-candidate Clinical Oncology at the Leiden University Medical Center, Leiden, The Netherlands. She is a clinician-scientist who conducts clinical research on a variety of conditions with special attention to redefining the approach of targeted therapy associated mucocutaneous adverse events. She is also an active member of the Skin Toxicity and the Mucositis Study Group of MASCC. Show full Bio
Paolo Bossi
Medical oncologist fully dedicated to head and neck cancer, with a comprehensive overview, from translational research through collaborations with molecular pathologists to quality of life. He works in National Cancer Institute of Milan and he is a co-founder of Italian Association of Supportive Care in Cancer (called NICSO), federated with MASCC. Show full Bio
Mike Brennan
Professor Mike Brennan is currently Professor and Chairman of the Department of Oral Medicine at Carolinas Medical Center, Charlotte, NC. He is also the Director of the Sjögren’s Syndrome and Salivary Disorders Center at Carolinas Medical Center. He is the immediate past-president of the International Society of Oral Oncology. Show full Bio
Larry Broadfield
Show full Bio
Jane Bryce
Show full Bio
Joseph Califano
Show full Bio
Alexandre Chan
Dr. Alex Chan is an Assistant Head and Associate Professor with the Department of Pharmacy at National University of Singapore (NUS)/ He is also a Specialist Pharmacist at the National Cancer Centre Singapore. He is also a Board of Director of MASCC. Show full Bio
Martin Chasen
Dr. Martin Chasen is currently the Medical Director, Palliative Care, The Ottawa Hospital Cancer Centre and the Medical Director of the Palliative Rehabilitation Program at the Élisabeth Bruyère Hospital, Ottawa. Dr. Chasen completed his undergraduate training in medicine and surgery at the University of Pretoria in South Africa, in 1983. He later went on to obtain a specialist degree in Internal Medicine and Medical Oncology as well as a Master of Philosophy (Palliative Medicine) at the University of Cape Town, South Africa. Show full Bio
Harvey Chochinov
Dr. Harvey Max Chochinov is a Distinguished Professor of Psychiatry at the University of Manitoba and Director of the Manitoba Palliative Care Research Unit, CancerCare Manitoba. His seminal publications addressing psychosocial dimensions of palliation have helped define core-competencies and standards of end-of-life care. He holds the only Canada Research Chair in Palliative Care. His research has covered diverse issues pertaining to palliative care and dignity at the end of life. Dr. Chochinov is also the Co-founder and Chair for the Canadian Virtual Hospice, a Fellow of the Royal Society of Canada and a Fellow of the Canadian Academy of Health Sciences. Show full Bio
Rebecca Clark-Snow
Show full Bio
James Cleary
Show full Bio
Elvira Correa
Oral Medicine, Head of the Dental Ambulatory of the Hematology and Blood Transfusion Center, University of Campinas, Brazil Show full Bio
Greg Crawford
Greg Crawford is a practicing palliative medicine physician and is currently the Mary Potter Associate Professor of Palliative Medicine at the University of Adelaide, South Australia. He has clinical responsibilities at Mary Potter Hospice, North Adelaide and community palliative care with Central Adelaide Palliative Care Service. His major research activities are the psychological issues for people and their carers at the end of life, and for clinicians. Show full Bio
David Currow
David Currow is Chief Cancer Officer New South Wales and Chief Executive Officer of the Cancer Institute NSW. He continues to hold the chair of Palliative and Supportive Services at Flinders University. Show full Bio
Andrew Davies
Dr Andrew Davies is Clinical Director of Department of Supportive & Palliative Care at Royal Surrey County Hospital / St. Luke's Cancer Centre in Guildford (United Kingdom). He is co-chair of the MASCC Palliative Care Study Group Show full Bio
Mellar Davis
Show full Bio
Liliana De Lima
Liliana De Lima is a native of Colombia, and has served for the past 14 years as the executive director of the International Association for Hospice and Palliative Care (IAHPC). She is one of the founders of the Latin American Association for Palliative Care (ALCP) and was its President for 6 years. Show full Bio
Marvin Delgado-Guay
Dr. Marvin Delgado Guay is Assistant Professor of the Department of Palliative Care and Rehabilitation Services at The University of Texas M.D. Anderson Cancer Center. His main interests are spirituality and religiosity and coping strategies, also interested in the education processes in palliative care and programs development. His main research interests include Symptom distress in advanced cancer patients including physical, psychosocial symptoms and spirituality/religiosity and spiritual distress. Other interests include management of older patients with cancer and topics related to aging and cancer such as frailty, cognitive impairment, and spiritual distress. Show full Bio
Georgia Demetriou
Medical Oncologist and Senior Consultant Charlotte Maxeke Johannesburg Academic Hospital(CMJAH) and Wits Donald Gordon Medical Centre Head of Medical Teaching Unit CMJAH Director and Chairperson South African Oncology Consortium Treasurer South African Society of Medical Oncology Special Interest in Breast and Colorectal Cancer Show full Bio
Avraham Eisbruch
Dr Eisbruch is professor of radiation oncology at the University of Michigan, Ann Arbor, US. His clinical research focuses on using advanced technology to reduce complications of chemo-irradiation of head and neck cancer. Show full Bio
Sharon Elad
Professor and Chair, Division of Oral Medicine, Eastman Institute for Oral Health, University of Rochester Medical Center; Clinical Chief, Hospital General Dentistry, Strong Memorial Hospital, University of Rochester Medical Center; Professor of Oncology, Wilmot Cancer Center, University of Rochester, Rochester, NY Show full Bio
Linda Elting
Dr. Linda Elting is Professor of Health Services Research at M D Anderson Cancer Center. She has spent the last three decades conducting research on the barriers that stand between patients and their best treatments. Show full Bio
Joel Epstein
Dr. Epstein has focused his career in oral medicine and oral oncology in clinical care and clinical and translational research. Show full Bio
Alessandra Fabi
Alessandra Fabi, MD, work at Regina Eòlena National CAncer Institute, Rome (Italy) She works on the field of breast cancer, CNS cancer nd supportive care in oncology Show full Bio
Carole Fakhry
Show full Bio
Petra Feyer
Proffesor of radiooncology. Head of the department Radiooncology Vivantes Clinic Berlin Neukoelln, Germany. Engaged in Supportive Care as chair of Supportive Care Group Germany and member of the MASCC/ESMO and ASCO antiemetic Guideline panel Show full Bio
Carme Font
I work as a clinician in an Outpatient cancer Clinics. I attend unscheduled visits in cancer patients with active anticancer therapy and/or palliative treatment. I also work as a consultant in the Emergency department for cancer patients to decide hospital admission vs. outpatient management of acute medical conditions. Show full Bio
Janet S. Fulton
Dr. Fulton is a professor, Indiana University School of Nursing and an oncology clinical nurse specialist. Her interest area is oral complications related to cancer and cancer treatment. Dr. Fulton is the editor of Clinical Nurse Specialist: The International Journal for Advanced Nursing Practice. A member of several professional organizations, she currently serves as treasurer for ISOO. Show full Bio
Rachel Gibson
Associate Professor Rachel Gibson graduated with a PhD in Medicine in 2004 having focused on the underlying pathogenesis of gut toxicity following chemotherapy. In 2004, she was awarded a Cancer Council South Australia Post-Doctoral Research Fellowship to continue her research into gut toxicity at the Royal Adelaide Hospital. She currently holds a tenured academic position and is the Head of her own research laboratory. Show full Bio
Paul Hesketh
. Paul J. Hesketh, M.D. is Chair of the Lahey Health Cancer Institute, Director of the Sophia Gordon Cancer Center and Director of Thoracic Oncology at Lahey Hospital & Medical Center in Burlington, Massachusetts. He is also Professor of Medicine at Tufts University School of Medicine Show full Bio
Holly M. Holmes
Dr. Holly Holmes is a geriatrician and prior pharmacist whose clinical and research interests are centered on better prescribing for vulnerable older adults with multiple comorbidities. Dr. Holmes attended medical school at The University of Texas-Houston Health Science Center. She completed her Internal Medicine residency and her Geriatrics fellowship training at the University of Chicago. Show full Bio
Allan Hovan
Dr. Allan Hovan is a Board-Certified Specialist in Oral Medicine who currently serves as the Department Head for the Provincial Program in Oral Oncology/Dentistry at the British Columbia Cancer Agency in Vancouver, Canada. His presentation will focus on oral, dental and prosthodontic function following cancer therapy. Show full Bio
Scott Howard
Show full Bio
David Hui
Dr. David Hui is a medical oncologist and palliative care specialist from MD Anderson Cancer Center, USA. Show full Bio
Liz Isenring
Show full Bio
Paul B Jacobsen
Paul Jacbosen is Associate Center Director for Population Scinece at Moffit Cancer Center at the University of South Florida, Tampa, FL, USA. For the past 25 years, Dr. Jacobsen's work has focused on using knowledge from the behavioral and social sciences to promote reductions in cancer risk, earlier detection of cancer, and improvements in quality of life following cancer diagnosis. Show full Bio
Didier Kamioner
Show full Bio
Dorothy M. K. Keefe
Dorothy Keefe is the Immediate Past-President of MASCC; she is a Medical Oncologist with a research interest in Regimen-related toxicity, particularly focussed on the GI Tract. She is Professor of Cancer Medicine at the University of Adelaide, and Service Director of the South Australian Cancer Service. Show full Bio
Jean Klastersky
Professor Klastersky has been Head of the Department of Medicine at the Institut Jules Bordet in Brussels and Professor of Medicine, Medical Oncology and Physical Diagnosis at the Université Libre de Bruxelles since 1977. He retired from these positions in 2005. Currently, he is the Coordinator of the “Programme des Soins Oncologiques” for the nine IRIS ( Interhospitalière Régionale des Infrastructures de Soins ) hospitals in Brussels and Consultant in medical oncology at the Institut Jules Bordet. Professor Klastersky was an intern and resident at the University Hospitals of the Université Libre de Bruxelles between 1962 and 1965, where he gained his MD (Docteur en Médecine, Chirurgie et Accouchements). From 1967 to 1968, he was Chief-Resident at Boston City Hospital and then a Research Fellow and Assistant in Medicine at Thorndike Memorial Laboratory Harvard Medical School. He became Chief of the Section of Infectious Diseases at the Institut Jules Bordet in 1970, before taking up the position of Head of the Department of Medicine in 1977. Professor Klastersky was a founder member of the European Lung Cancer Working Party and has been his President since 1978 until 2003. He was President (and founder member) of the International EORTC Antimicrobial Therapy Project Group between 1979 and 1987 and the Group’s Secretary General from 1987 to 2000. He was President (and founder member) of the Multinational Association for Supportive Care in Cancer (MASCC) from 1990 to 2000. He is Visiting Professor of Medical Oncology at the Charles University in Prague, since 1994. Professor Klastersky is a member of the American Society of Clinical Oncology, the American Association of Cancer Research, the European Society of Medical Oncology, the American Society of Microbiology, the Infectious Diseases Society of America, the International Association for the Study of Lung Cancer, the “Royale Académie de Médecine” of Belgium and various other international and national medical and/ Show full Bio
Mario Lacouture
Dr. Mario Lacouture is a board-certified dermatologist with special interest in dermatologic conditions that result from cancer treatments. My clinical career has been focused on the recognition and management of side effects affecting the skin, hair, and nails of cancer patients and survivors. Show full Bio
Raj Lalla
Dr. Lalla is a tenured Associate Professor of Oral Medicine at the University of Connecticut Health Center. He holds several leadership positions within MASCC/ISOO including Chair, Mucositis Study group; Chair, MASCC Guidelines Committee; and Member, MASCC Board of Directors. Show full Bio
Manon Lemonde
Manon Lemonde is the Chair of the MASCC Education Study Group for the last 3 years. She is also a registered nurse and a researcher using evidence to disseminate the information and integrate it in her teaching. Show full Bio
Wojciech Leppert
Show full Bio
Richard Logan
Richard is the Head of Oral Diagnostic Sciences in the School of Dentistry at the University of Adelaide. He is co-director of the Adelaide Mucostis Research Group and has an interest in aspects of the pathobiology of oral (and gastrointestinal) mucositis. Show full Bio
Charles Loprinzi
Show full Bio
Cesar Migliorati
Professor and Chair, Department of Diagnostic Sciences and Oral Medicine, University of Tennessee Health Science Center, College of Dentistry. MASCC/ISOO member, Chair of MASCC Bone Study Group. Show full Bio
Supriya Gupta Mohile
Supriya Gupta Mohile, M.D, M.S. is a board-certified geriatrician and oncologist at the University of Rochester and has clinical expertise in treating patients with genitourinary and gastrointestinal cancers. She directs the geriatric oncology clinical and research program at the University of Rochester and is actively involved in the Cancer and Aging Research Group. Show full Bio
Alex Molasiotis
Professor Alex Molassiotis is Chair Professor of Nursing and Head of the School of Nursing aw well as Angel S.P. Chan Lau Endowed Professor in HEalth & Longevity, The Hong Kong Polytechnic University Show full Bio
Devan Moodley
Show full Bio
Barbara Murphy
Show full Bio
Karen Mustian
Dr. Mustian is an Associate Professor in the Departments of Surgery, Radiation Oncology and Public Health Sciences at the University of Rochester Medical Center in the James P. Wilmot Cancer Institute. She is an internationally recognized expert in exercise oncology and rehabilitation for supportive care among cancer patients and survivors. Show full Bio
Raj Nair
Raj is Discipline Head of Oral Medicine, Oral Pathology and Human Diseases at Griffith University, Gold Coast, and Oral Medicine Consultant, Department of Haematology and Oncology, Gold Coast Hospital, Queensland Health, Australia. He has been active in MASCC since late nineties and currently a board member of the ISOO. Show full Bio
Ourania Nicolatou-Galatis
Show full Bio
Karin Olson
Dr. Olson is a professor in the Faculty of Nursing at the University of Alberta and holds a cross-appointment to the Division of Palliative Medicine in the Faculty of Medicine and Dentistry at the University of Alberta. Show full Bio
Ian Olver
Professor Ian Olver is a medical oncologist and researcher. He is currently the CEO of Cancer Council Australia and a Clinical Professor at University of Sydney. He currently serves on the MASCC Executive as Treasurer. Show full Bio
Petra Ortner
Petra Ortner is a pharmacist from her education. Since more than 20 years she is specialised on medical communication with focus in oncology. She is board member of the German supportive care in cancer group and the co-chair of the 2013 MASCC/ ISOO Symposium. Show full Bio
Rekha Parameswaran
Show full Bio
Ira R. Parker
Show full Bio
Francisco Luis Pimentel
Show full Bio
Pongpak Pittayapan
Dr. Pongpak Pittayapan is clinical nurse specialist at Mahidol University, Bangkok, Thailand. She join MASCC since 2007 till now and co-chair of Multinational Association of Supportive Care in Cancer (MASCC) Education Study Group. Show full Bio
Philippe Poulain
Show full Bio
Harry Raftopolous
Show full Bio
Lois Ramondetta
Dr. Ramondetta joined the M.D. Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine after completing her fellowship in 2000. She holds a full time Professor position at M. D. Anderson and she also holds the position of Chief of Gynecologic Oncology at Lyndon Baines Johnson General Hospital, Harris County Hospital District. She is extremely active in developing and running investigator initiated and national clinical treatment trials in both locations. Dr. Ramondetta's clinical research interest as focused on both barriers to care, treatment of cervical and uterine cancer, as well as determining the effect of coping, spirituality and communication during cancer treatment on quality of life and stress. Show full Bio
Bernardo L. Rapoport
Dr. Bernardo Rapoport. Current Positions: Medical Oncology Private Practice and Private Oncology Clinical Trial Unit in Rosebank, Johannesburg, South Africa. Longstanding MASCC member. Chairman of the MASCC Neutropenia, Infection and Myelosupression Study Group. He is also a member of the MASCC Antiemetic Guidelines Working Group as well as the MASCC Guideline Committee. He has published widely with more than 70 articles in peer reviewed journals. He has presented more than 100 abstracts locally and internationally (including ASCO, MASCC and ESMO). Show full Bio
Carla Ripamonti
Carla Ida Ripamonti, M.D. specialized in medical oncology and clinical pharmacology , Head of Supportive Care in Cancer Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milano, Italy, Lifetime Board Advisers of International Association Hospice & Palliative Care (IAHPC); European Society Medical Oncology (ESMO) Faculty Member Educational Committee Supportive and Palliative Care; Member of the Directors of the ESMO Palliative Care Working Group (PCWG), Italian Member of Multinational Association Supportice Care Cancer (MASCC); Vice Director Network Italiano Cure di Supporto in Oncologia (NICSO) Show full Bio
Cynthia Rittenberg
Show full Bio
Fausto Roila
I am the Director of the Medical Oncology Division of Terni Hospital - Italy. I dedicated myself to Antiemetic Research for 30 years. I am involved in the evaluation of new antineoplastic agents carried out by the Italian Agency of Drugs and by the Committee of the Hospital Therapeutic Formulary of Umbria. Show full Bio
Kenneth V. Rolston
Show full Bio
Deborah Saunders
Show full Bio
Penelope Schofield
Penny Schofield is currently Director, Department of Cancer Experience Research at the Peter MacCallum Cancer Centre in Victoria and an Honorary Principal Research Fellow, University of Melbourne. A behavioural scientist with over 25 years’ experience, her research program adopts a comprehensive approach to developing and delivering effective and sustainable interventions, which are underpinned by excellent clinician-patient communication, promote self-care, improve emotional and physical outcomes for patients, and alleviate burden on the health system. Show full Bio
Lee Schwartzberg
Lee Schwartzberg, M.D., F.A.C.P. is a senior partner and Medical Director at The West Clinic in Memphis, TN. He is professor of medicine and chief of the division of Hematology and Oncology at the University of Tennessee Health Science Center. Show full Bio
Stephen T. Sonis
Chief, Divisions of Oral Medicine, Brigham and Women’s Hospital and the Dana-Farber Cancer Institute Chief Scientific Officer, Biomodels, LLC Show full Bio
Fred Spijkervet
Show full Bio
Karen Steindorf
Prof. Karen Steindorf is Head of the Unit of Physical Activity and Cancer at the German Cancer Research Center (DKFZ) and the National Center for Tumor Diseases (NCT) in Heidelberg, Germany. In the field of exercise and fatigue in cancer patients, Prof. Steindorf is currently principal investigator of the BEATE and the BEST study for breast cancer patients, as well as several other observational and clinical studies. Show full Bio
Lillian Sung
Show full Bio
Petrina Sweeney
Dr Petrina Sweeney from Glasgow University is a Clinical Senior Lecturer/honorary consultant in Special Care Dentistry at Glasgow University Dental Hospital & School Show full Bio
Winston Tan
Chair GU Medical Oncology Mayo Clinic Florida, Associate Professor Mayo Clinic College of Medicine ,Clinical expert in Oncology Clinical trials and quality of life issues Show full Bio
Jakica Tancabelic
Show full Bio
Konishi Tatsuya
Show full Bio
Véronique Tual
Show full Bio
Marianne van de Wetering
Senior Paediatric oncologist from 1997 onwards at the .Emma Childrens hospital Amsterdam/ Academic Medical centre the netherlands Special Interest: supportive care in paediatric oncology for which she is known both national and international. Her research focuses on infectious complications in paediatric oncology and on fertility preservation in children who start their treament for cancer. Show full Bio
Irma Verdonck-de-leeuw
Irma Verdonck-de Leeuw (1963) graduated as a psychologist, speech pathologist, and linguist. She is professor at the Department of Otolaryngology – Head & Neck Surgery of VU University Medical Center (VUmc) / Cancer Center Amsterdam, and the Department of Clinical Psychology of VU University in Amsterdam, the Netherlands. She holds the chair “Living with Cancer: innovative care programs and e-health” established by the Dutch Cancer Society (KWF) / Alpe d’HuZes Foundation. Show full Bio
Jamie Hayden Von Roenn
Show full Bio
Declan Walsh
Show full Bio
Thomas Walsh
Show full Bio
Tuomas Waltimo
Show full Bio
Dave Warr
Dr. Warr is an associate professor at the University of Toronto in the Department of Medicine and is the head of breast cancer medical oncology as well as a pain consultant at the Princess Margaret Hospital. He has been part of the antiemetic guidelines group since its initial meeting in 1997 and immensely enjoys lecturing particularly when he can inject a note of controversy. Show full Bio
Noam Yarom
Dr. Noam Yarom is a senior lecturer of oral medicine and the program director of postgraduate oral medicine in the Department of Oral Pathology and Oral Medicine at the Tel-Aviv University. He is also the director of the Oral Medicine Clinic at the Sheba Medical Center, Tel-Hashomer. Dr. Yarom is the immediate past president of the Israeli Society of Oral Medicine and serves as region V representative at the European Association of Oral Medicine board. His main research interests are oral cancer and supportive care of cancer patients and he published extensively on these topics. Show full Bio
Sriram Yennu
Show full Bio